SN
Syntara Limited
SNT.AX · ASX
$0.02 -4.00% (-$0.00)
1M +4.17%
Market Cap $36.0M
P/E Ratio -
Div. Yield -
ROE 77.61%
Bulios Fair Price
$0.01
58.3% downside
Trenutna cena
$0.024
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNT.AX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
82 /100
Cheap P/B 2.22x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 14.49%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 47.01%
ROIC 67.34%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 6.57x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
1 /100
Unstable Profitable years 0
Beta 0.18x
EPS volatility 257.99%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNT.AX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Gary Jonathan Phillips
Employees
85
Headquarters
Frenchs Forest
Prihajajoči dogodki
05 FEB.
Earnings
Upcoming earnings report